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WI-2, a cell surface immunoglobulin SF protein of
unknown function, associates with tetraspanins CD9
and CD81 with high stoichiometry. Overexpression of
EWI-2 in A431 epidermoid carcinoma cells did not alter
cell adhesion or spreading on laminin-5, and had no effect
on reaggregation of cells plated on collagen I (
 
 
 
2
 
 
 
1 integrin
ligand). However, on laminin-5 (
 
 
 
3
 
 
 
1 integrin ligand),
A431 cell reaggregation and motility functions were markedly
impaired. Immunodepletion and reexpression experiments
revealed that tetraspanins CD9 and CD81 physically link
EWI-2 to 
 
 
 
3
 
 
 
1 integrin, but not to other integrins. CD81 also
E
 
controlled EWI-2 maturation and cell surface localization.
EWI-2 overexpression not only suppressed cell migration,
but also redirected CD81 to cell ﬁlopodia and enhanced
 
 
 
3
 
 
 
1–CD81 complex formation. In contrast, an EWI-2
chimeric mutant failed to suppress cell migration, redirect
CD81 to ﬁlopodia, or enhance 
 
 
 
3
 
 
 
1–CD81 complex for-
mation. These results show how laterally associated EWI-2
might regulate 
 
 
 
3
 
 
 
1 function in disease and development,
and demonstrate how tetraspanin proteins can assemble
multiple nontetraspanin proteins into functional complexes.
 
Introduction
 
The laminins are major components of normal and patho-
logical basement membranes. Major cellular receptors for
laminins are 
 
 
 
3
 
 
 
1, 
 
 
 
6
 
 
 
1, 
 
 
 
6
 
 
 
4, and 
 
 
 
7
 
 
 
1 integrins
(Colognato and Yurchenco, 2000). The 
 
 
 
6
 
 
 
4 integrin
anchors normal epithelial cells to laminin-5 in hemidesmo-
somes (Borradori and Sonnenberg, 1999), whereas 
 
 
 
3
 
 
 
1
integrin is implicated in laminin-5–mediated cell motility
(Nguyen et al., 2000). Laminin-binding integrins also maintain
epithelial integrity, and support kidney and lung morpho-
genesis (Kreidberg et al., 1996; DiPersio et al., 1997).
Laminin-binding integrins (
 
 
 
3
 
 
 
1, 
 
 
 
6
 
 
 
1, 
 
 
 
6
 
 
 
4, and 
 
 
 
7
 
 
 
1)
are further distinguished from other integrins by their forma-
tion of robust complexes with tetraspanins (Berditchevski,
2001; Sterk et al., 2002).
Tetraspanin proteins contain four transmembrane domains,
one small and one large extracellular loop, and short, cyto-
plasmic NH
 
2
 
 and COOH termini (Berditchevski, 2001;
Boucheix and Rubinstein, 2001). Tetraspanins may specifically
regulate integrin-dependent cell motility and morphology,
but typically do not affect static cell adhesion (Stipp and
Hemler, 2000; Zhang et al., 2002). Tetraspanins associate
with integrins, Ig superfamily proteins, membrane-bound
growth factors, growth factor receptors, and other tetraspanins
to form tetraspanin-enriched microdomains on the cell
surface (Berditchevski, 2001; Boucheix and Rubinstein,
2001; Hemler, 2003).
To gain insight into tetraspanin function, we used mass
spectrometry to identify novel associated proteins. Tetraspanins
CD9 and CD81 were targeted because of their unique pattern
of associated proteins (Stipp et al., 2001b), which includes
EWI-2 (also called PGRL), as a member of a subfamily of
four distinct but related IgSF proteins (Clark et al., 2001;
Stipp et al., 2001a; Charrin et al., 2003a). In relatively strin-
gent detergent conditions (1% Brij 96/97), EWI-2–CD81
and EWI-2–CD9 complexes are stable, fully soluble, limited
in size (
 
 
 
4 million D), highly stoichiometric, and can be
chemically cross-linked, indicative of direct protein–protein
interactions (Claas et al., 2001; Stipp et al., 2001a,b; Charrin
et al., 2003a).
EWI-2 is widely expressed, with prominent mRNA ex-
pression in the brain (Clark et al., 2001; Stipp et al., 2001a),
and protein expression on peripheral blood lymphocytes and
hepatocytes, where it colocalizes with CD81 (Charrin et al.,
2003a). We hypothesized that, as a major tetraspanin partner,
EWI-2 might regulate cell motility on laminin, given the
preferential association of tetraspanins with laminin-binding
integrins. Our results establish EWI-2 as a novel regulator of
cell reaggregation and motility on laminin-5 and reveal CD9
and CD81 as key linkers in a physical complex of EWI-2
with 
 
 
 
3
 
 
 
1 integrin, a laminin-5 receptor.
 
The online version of this article includes supplemental material.
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Results
 
Expression of EWI-2 in A431 epithelial carcinoma cells
 
To study EWI-2 function, we transduced A431 epidermoid
carcinoma cells with a retroviral vector encoding COOH-
terminally FLAG-tagged EWI-2 (A431 EWI-2 cells) or with
empty vector (A431 IZ cells). We detected intact EWI-2
(and a 50-kD fragment) in lysates of surface-biotinylated
A431 EWI-2 cells, but not A431 IZ control cells (Fig. 1 B,
inset). The level of EWI-2 expression achieved in A431
EWI-2 cells is not excessively high, but rather, is comparable
to endogenous EWI-2 expression in other cell lines (e.g.,
293 embryonic kidney cells; unpublished data). Levels of
laminin-5 receptors (
 
 
 
3
 
 
 
1 and 
 
 
 
6
 
 
 
4) on A431 cells were
unaffected by EWI-2 expression. Also, A431 EWI-2 and
A431 IZ cells showed equal static cell adhesion (unpub-
lished data) and equal spreading on laminin-5 (Fig. 1, A and
B). Anti-
 
 
 
6 antibody failed to alter A431 cell spreading (Fig.
1, C and D), indicating that 
 
 
 
6
 
 
 
4 is not required. In con-
trast, anti-
 
 
 
3 blocking antibody strongly impaired spreading
of both cell types (Fig. 1, E and F). Hence, 
 
 
 
3
 
 
 
1 mediates
A431 cell spreading on laminin-5, as seen for other cell types
(Xia et al., 1996; DiPersio et al., 1997). An 
 
 
 
6 contribution
to spreading was uncovered when anti-
 
 
 
3 and -
 
 
 
6 antibod-
ies were used in combination (Fig. 1, compare G and H
with E and F), with nearly complete inhibition by both anti-
bodies together, 
 
 
 
50% reduction with anti-
 
 
 
3 antibody,
and minimal reduction with anti-
 
 
 
6 antibody (Fig. 2).
Thus, 
 
 
 
3
 
 
 
1 alone is sufficient for A431 cell spreading, but
 
 
 
6
 
 
 
4 can partially compensate when 
 
 
 
3
 
 
 
1 function is
blocked.
 
EWI-2 overexpression impairs A431 cell reaggregation 
on laminin-5
 
Although EWI-2 overexpression did not alter 
 
 
 
3 or 
 
 
 
6 in-
tegrin expression, adhesion, or spreading functions in A431
cells, dramatic effects were seen in longer-term assays. After
enzymatic dissociation, a single-cell suspension of A431
cells replated on laminin-5 (Fig. 3 A) began to reaggregate.
Within 5–6 h, many cells clustered into small islands (Fig.
3 B) that progressively fused to reestablish the epithelial
sheet morphology of A431 cells by 18–24 h (Fig. 3 C). Like
the A431 parental cell line, A431 IZ control cells reaggre-
gated into characteristic clusters within 5–6 h (Fig. 4 A),
with 20% of the cells in clusters of four cells or more and
only 
 
 
 
50% remaining as single cells (Fig. 4 C). By con-
trast, reaggregation of A431 EWI-2 cells was dramatically
Figure 1. EWI-2 overexpression does not affect A431 cell spreading 
on laminin-5. A431 IZ control cells or A431 EWI-2 cells were 
plated in serum-free medium on laminin-5–coated coverslips with 
no antibodies (A and B), or in the presence of 5  g/ml GoH3 anti- 6 
integrin (C and D), 10  g/ml A3-IIF5 anti- 3 integrin (E and F), or 
both anti- 3 and - 6 antibodies (G and H). Cells were fixed after 20 
min and photographed with phase contrast. Inset in B shows anti-
FLAG EWI-2 immunoprecipitate from cell surface–biotinylated 
A431 EWI-2 cells (EWI-2) or A431 IZ control cells (IZ) developed 
with HRP-ExtrAvidin
®. Mol wt markers (kD) are indicated.
Figure 2. Quantitation of A431 IZ cells and A431 EWI-2 cell 
spreading assays on laminin-5. The areas of 20–45 cells per cover-
slip were measured using Scion Image v1.62 software. Specific 
spreading was calculated by subtracting the mean area of cells fixed 
immediately after plating from the mean area of cells fixed at the 
end of the assay. Error bars indicate the SEM for each coverslip. Two 
coverslips per condition were examined; results for each coverslip 
are shown individually. Asterisk Indicates statistically significant 
difference between antibody-treated cells and the coverslips in the 
no antibody controls (P   0.0005; Bonferroni post-ANOVA t test). 
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impaired (Fig. 4 B), as they exhibited a fivefold reduction
in cluster formation and a corresponding increase in the
proportion of single cells (Fig. 4 C). A431 EWI-2 cells did
eventually reaggregate after overnight incubation (unpub-
lished data). Reduced aggregation of A431 EWI-2 cells was
not due to decreased viability on laminin-5. Between 1 and
24 h after plating on laminin-5, A431 IZ and A431 EWI-2
cells expanded by 124 and 113%, respectively, as measured
by tetrazolium bromide (MTT) assay on quadruplicate
wells. On the 
 
 
 
2
 
 
 
1 integrin ligand (collagen I), both cell
types reaggregated with equal efficiency (Fig. 4, D–F). An-
tibody inhibition experiments confirmed the 
 
 
 
2
 
 
 
1 depen-
dence of A431 attachment and spreading on collagen I (un-
published data).
 
Decreased motility of EWI-2–overexpressing cells
 
The reduced reaggregation observed in Fig. 4 could result
from a failure of normally migrating cells to form stable cell–
cell contacts, or from decreased cell motility leading to de-
creased opportunity for cell–cell interactions. In a time-lapse
video (Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200309113/DC1), A431 IZ control cells exhibited
robust random motility upon plating on laminin-5, whereas
A431 EWI-2 cells attached and spread, but migrated at far
slower rates, or not at all. Tracking of individual A431 EWI-2
cells revealed a 60–70% decrease in the mean migration rate
(Fig. 5 A), an 84–88% decrease in the number of 10-min in-
tervals with a mean rate of 30 
 
 
 
m/h or more, and a nearly
twofold increase in the number of 10-min intervals with a
mean migration rate of 10 
 
 
 
m/h or less (Fig. 5 B). A similar
result was observed for cells migrating in the presence of
an anti-
 
 
 
6 integrin-blocking antibody (unpublished data).
Thus, 
 
 
 
6
 
 
 
4 needn’t be engaged with ligand for EWI-2 to
regulate 
 
 
 
3
 
 
 
1 function. To begin to define which region of
EWI-2 is responsible for its anti-migratory activity, we in-
troduced into A431 cells a chimeric EWI-2 protein, with the
EWI-2 cytoplasmic tail replaced by that of CD2. This chi-
mera, EW2xCD2c, was expressed on the surface of A431
cells and engaged a similar fraction of 
 
 
 
3 integrin in com-
plexes (see Fig. 9, A and B), but failed to impair migration
on laminin-5 (Fig. 5 C).
 
Altered CD81 localization in EWI-2–overexpressing cells
 
No obvious differences in 
 
 
 
3
 
 
 
1 localization were observed
as A431 IZ, A431 EW2xCD2c, and A431 EWI-2 cells all
Figure 3. Reaggregation of dispersed A431 cell on laminin-5. 
A431 cells were enzymatically dissociated and plated in serum-free 
medium on laminin-5. The same field of cells was monitored 
periodically over a period of 21 h while being maintained in a 
microscope stage incubator. (A) Cells just after plating; (B) after 5 h; 
(C) after 21 h.
Figure 4. EWI-2 expression impairs A431 cell reaggregation on 
laminin-5. A431 IZ control or EWI-2 cells were plated, after enzymatic 
dissociation, in serum-free medium on coverslips coated with 
laminin-5 (A–C) or collagen I (D–F). After 5 h, cells were fixed and 
photographed in phase contrast, revealing several clusters of four 
or more A431 IZ cells in most fields, as indicated by asterisks in A. 
By contrast, few clusters of A431 EWI-2 cells were observed in B. 
(C) Quantitation of three separate experiments (two coverslips per 
condition in each experiment, five fields per coverslip) revealed a 
statistically significant decrease in the percentage of clustered A431 
EWI-2 cells on laminin-5 (P   0.005; t test), and a corresponding 
increase in the percentage of single cells (P   0.02; t test). After 5 h 
on collagen I, both cell types had similar clustering properties as 
shown in photos (D and E) and by quantitation (F). 
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EW2xCD2c cells (Fig. 6, compare F to D and E; L to J and
K). Especially striking was the enhanced punctate CD81
staining on the filopodia of A431 EWI-2 cells. In A431 IZ
and EW2xCD2c cells, CD81 staining was more evenly dis-
tributed and was not as concentrated at the cell perimeter. In
phase contrast (Fig. 6, G–I), A431 EWI-2 cells were typi-
cally more symmetrical, consistent with their reduced migra-
tion. This increased symmetry by itself does not explain the
differences in CD81 localization because A431 IZ and
EW2xCD2c cells with similar morphology still failed to
show altered CD81 staining (Fig. 6, D, E, G, and H; ar-
rows). An antibody to 
 
 
 
4 integrin, which is not expressed by
A431 cells, revealed a low level of background staining (Fig.
6 M). Thus, although EWI-2–overexpressing cells did not
show altered localization of 
 
 
 
3
 
 
 
1 integrin itself at the cell
periphery, more CD81 became concentrated in perimeter
filopodia, consistent with increased physical association with
 
 
 
3 (see Fig. 9 D).
 
EWI-2 physically associates with 
 
 3 1 integrin
Because EWI-2 and  3 integrin can each associate with
both CD9 and CD81 (Berditchevski et al., 1996; Clark et
al., 2001; Stipp et al., 2001a; Charrin et al., 2003a), we
hypothesized that CD9 and/or CD81 might therefore
link  3 1 to EWI-2. Indeed, compared with the amount
of EWI-2 recovered directly by anti-FLAG immunopre-
cipitation (Fig. 7 A, lane 1), a substantial fraction of EWI-2
could also be recovered in an  3 1 immunoprecipitate
(Fig. 7 A, lane 5) prepared from a 1% Brij 96 lysate of
A431 EWI-2 cells. In contrast, no EWI-2 was detected in
association with integrins  2 1 (Fig. 7 A, lane 6) or  6 4
(Fig. 7 A, lane 7). A substantial amount of EWI-2 was
also found associated with tetraspanins CD81 and CD9
(Fig. 7 A, lanes 2 and 3), as observed previously. Associa-
tion of EWI-2 with tetraspanin CD151 (Fig. 7 A, lane 4)
is consistent with CD151 being tightly associated with
 3 1 integrin (Yauch et al., 1998). The recovery of a
smaller amount of EWI-2 (Fig. 7 A, compare lane 4 with
lane 5) likely occurs because the 5C11 epitope on CD151
is partly obscured in Brij 96 detergent conditions (Yang et
al., 2002).
Immunoprecipitation of cell surface–biotinylated mole-
cules confirmed that the EWI-2– 3 1 complex indeed oc-
curs on the cell surface (Fig. 7 B). Using anti-FLAG immu-
noprecipitation, intact EWI-2 (70 kD) and the 50-kD EWI-2
cleavage product (Stipp et al., 2001a) were obtained from
A431 EWI-2 cells (Fig. 7 B, lane 1), but not from mock in-
fected (IZ), or parental (P) cells (Fig. 7 B, lanes 2 and 3).
These same EWI-2 bands were present in immunoprecipita-
tions of CD151 (Fig. 7 B, lanes 10–12), and  3 integrin
(Fig. 7 B, lanes 13–15), but not  6 integrin (Fig. 7 B, lanes
16–18) or  2 integrin (Fig. 7 B, lanes 19–21). Levels of cell
surface–biotinylated  3 1 integrin were similar in all three
cell types (e.g., Fig. 7 B, lanes 13–15), consistent with flow
cytometry results (unpublished data). As measured by densi-
tometry, in A431 EWI-2 cells,  4 times more EWI-2 was
associated with  3 1 integrin (Fig. 7 B, compare lane 13
with lanes 14 and 15), consistent with exogenous EWI-2 be-
ing present approximately fourfold above background levels
in A431 cells.
Figure 5. Impaired migration of A431 EWI-2 cells on laminin-5. 
(A) In two separate trials, XY locations of individual cells were 
determined once every 10 min using Scion Image v1.62 software, 
and the average migration rate was calculated from the series of 
XY measurements using KaleidaGraph v3.05 software (Abelbeck 
Software). A431 EWI-2 cells migration rates were 60–70% lower 
than those of A431 IZ control cells (*, P   0.0001; t test). (B) The 
total set of migration rates calculated during each 10-min observation 
period was binned to show the distribution of migration rates for 
A431 IZ cells and A431 EWI-2 cells. On average, A431 EWI-2 
cells spent 84–88% less time moving  30  m/h, and 1.6–2-fold 
more time moving  10  m/h (see Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200309113/DC1). (C) Mean 
migration rates of A431 IZ, A431 EW2xCD2c, and A431 EWI-2 
cells were measured as in A. A431 EWI-2 cell migration rate was 
reduced  60% compared with A431 IZ or A431 EW2xCD2c 
(*, P   0.001; **, P   0.002; Bonferroni post-ANOVA t test). 
There was no statistically significant difference between the migration 
rates of A431 IZ and A431 EW2xCD2c cells (P   0.1). For all 
experiments in this figure, coverslips were coated with 0.5  g/ml 
rat laminin-5 and blocked with serum-free medium. Additional 
details regarding data acquisition and videomicroscopy appear 
in Zhang et al. (2002).
showed smooth, bright staining over the surface, with
prominent labeling of filopodia at the cell perimeters (Fig.
6, A–C). In contrast, CD81 was more prominent at the
cell periphery in A431 EWI-2 cells, compared with IZ orEWI-2 regulates integrin functions | Stipp et al. 1171
Figure 6. Altered CD81 localization 
in A431 EWI-2 cells. A431 IZ, A431 
EW2xCD2c, and A431 EWI-2 cells were 
plated on laminin-5–coated coverslips in 
serum-free medium and fixed after 3.5 h. 
Cells were stained for  3 integrin with 
the A3X8 mAb (A–C), CD81 with the 
JS64 mAb (D–F and J–L), or  4 integrin 
with the B5G10 mAb (M). Staining was 
visualized with FITC-goat anti–mouse 
secondary antibody. Although  3 local-
ization appeared similar in all three cell 
types, CD81 was strongly concentrated 
in filopodia at the perimeters of A431 
EWI-2 cells. G–I shows phase-contrast 
images of the same fields as in D–F, to 
reveal cell morphology. J–L show expan-
sion of regions boxed in D–F and G–I. 
Arrows in D, E, G, and H indicate a 
subset of cells with a round, symmetrical 
morphology that nevertheless failed to 
demonstrate the striking concentration 
of CD9 and CD81 at the cell perimeter 
that was observed in the EWI-2–overex-
pressing cells.
Figure 7. EWI-2 associates with tetraspanins and 
 3 1 integrin. (A) A431 EWI-2 cells ( 5   10
6) 
expressing FLAG-tagged EWI-2 were lysed in 1% 
Brij 96. Equal volumes of the lysate were used for 
immunoprecipitations with anti-FLAG agarose or 
with anti-integrin or -tetraspanin antibodies. The 
blot was developed with biotinylated anti-FLAG 
antibody followed by HRP-ExtrAvidin
® to detect 
coprecipitating EWI-2. (B) A431 EWI-2 cells (EWI-2), 
A431 IZ cells (IZ), and A431 parental cells (P) were 
labeled with sulfo-NHS biotin and lysed in 1% Brij 
96. Lysates were immunoprecipitated with anti-
FLAG agarose or antibodies to the indicated tetra-
spanins and integrins, followed by blotting with 
HRP-ExtrAvidin
®. EWI-2* designates a 50-kD EWI-2 
cleavage product, and two electrophoretic forms 
of CD9 are indicated.  7   10
5 cell equivalents 
were used for each immunoprecipitation. Flow 
cytometry results confirm that CD9, CD81, CD151, 
and  3 1 expression levels are similar in the different 
cell types. The bands of  210 kD in the  6 lanes 
(16–18) and CD151 lanes (10–12) correspond to 
integrin  4, a major  6 partner in A431 cells 
(Rabinovitz et al., 1999).  6 4 is known to associate 
with CD151 (Sterk et al., 2000). Densitometry 
indicated an approximate fourfold increase in 
 3-associated EWI-2 upon EWI-2 overexpression. 
Similar results were obtained in two independent 
experiments.1172 The Journal of Cell Biology | Volume 163, Number 5, 2003
EWI-2– 3 1 complexes: a critical role for tetraspanins
Three lines of evidence indicate that tetraspanins play a
key role in linking EWI-2 to  3 1. First, tetraspanins
CD9 and CD81 associate with both EWI-2 and  3 1.
Immunoprecipitations of CD9 (Fig. 7 B, lanes 4–6) and
CD81 (Fig. 7 B, lanes 7–9) yielded both  3 1 integrin
and EWI-2, with higher levels of EWI-2 (Fig. 7 B, lanes 4
and 7) obtained from EWI-2–overexpressing cells. Inte-
grins ( 2 1,  6 4) not associating with CD9 and CD81
at the same time failed to show associated EWI-2 (Fig. 7
B, lanes 16–21). Second, removal of CD9 and CD81 re-
sulted in diminished EWI-2– 3 1 association. After im-
munodepletion with anti-CD9 and -CD81 antibodies,  3
integrin immunoprecipitation yielded a level of EWI-2
(Fig. 8 A, lane 5) that was 85% reduced (as measured by
densitometry) compared with that seen in control immu-
nodepletions (Fig. 8 A, lanes 4 and 6). Removal of CD9
and CD81 was essentially complete, as seen in a subse-
quent CD81 immunoprecipitation (Fig. 8 A, lane 2),
whereas mock immunodepletion or  2 integrin depletion
failed to remove CD9 and CD81 or associated EWI-2
(Fig. 8 A, lanes 1 and 3). Conversely,  2 integrin was all
removed by  2 immunodepletion (Fig. 8 A, lane 9), but
not by mock or CD9/CD81 depletion (Fig. 8 A, lanes 7
and 8). Because CD9/CD81 depletion removed only a
fraction ( 10%) of total  3 1 integrin (Fig. 8 A, com-
pare lane 4 with lane 5), most  3 1 appears not to be as-
sociated with CD9, CD81, or EWI-2. Third, the intro-
duction of CD81 into CD81-deficient U937 monocytic
leukemia cells (Hamaia et al., 2001) resulted in EWI-2–
 3 1 association. Immunoprecipitation of  3 yielded
FLAG-tagged EWI-2 when CD81 was present (Fig. 8 B,
lane 6), but not when absent (Fig. 8 B, lane 5). Control
CD81 immunoprecipitations from CD81
  cells yielded
EWI-2 (Fig. 8 B, lane 4) and  3 integrin (Fig. 8 B, lane
8), as well as CD81 itself (Fig. 8 B, lane 12), whereas
CD81 immunoprecipitations from CD81
  cells did not
(Fig. 8 B, lanes 3, 7, and 11). Conversely,  3 immunopre-
cipitation yielded CD81 only when CD81 was present
(Fig. 8 B, compare lane 14 with lane 13). Immunoblot-
ting of directly immunoprecipitated  3 confirmed that
 3 levels were similar in CD81
  and CD81
  cells (Fig. 8
B, lanes 9 and 10). Although smaller biosynthetic precur-
sors of  3 were present in the total  3 blot (Fig. 8 B, lanes
9 and 10), exclusively the mature form of  3 integrin as-
sociated with CD81 (Fig. 8 B, lane 8), as previously ob-
served (Kazarov et al., 2002).
Although EWI-2 was present in both CD81
  and
CD81
  cells, EWI-2 levels were somewhat lower in the
CD81
  cells, and much of the EWI-2 protein was shifted
to a slightly lower size (Fig. 8 B, lanes 1 and 2). Immu-
noprecipitation of FLAG-tagged, cell surface–biotinylated
EWI-2 established that only a small amount of EWI-2 was
on the surface of CD81
  cells (Fig. 8 C, top; lane 1), in
contrast to the abundant EWI-2 on the surface of CD81
 
cells (Fig. 8 C, lane 2). Hence, in the absence of CD81,
EWI-2 remains mostly in an incompletely glycosylated,
immature form that does not reach the U937 cell surface.
Similar amounts of  3 integrin appeared on the surface of
CD81
  and CD81
  cells (middle), and cell surface labeled
CD81 was detected only in CD81
  cells (lane 2, bottom).
Thus, CD81 associates relatively early in biosynthesis with
EWI-2 and then facilitates EWI-2 trafficking to the cell
surface, where it is assembled into an EWI-2–CD81– 3
integrin complex.
Figure 8. Tetraspanins support EWI-2- 3 1 integrin association. 
(A)  10
7 A431 EWI-2 cells were labeled with sulfo-NHS biotin and 
lysed in 1% Brij 96. Equal portions of lysate were depleted three 
times with protein G alone (mock) or with protein G plus anti-
tetraspanin or  2 integrin antibodies. Depletions are indicated at the 
top of the figure. Depleted lysates were further divided and immuno-
precipitated with anti-CD81, anti- 3 integrin, or anti- 2 integrin 
antibodies conjugated to agarose followed by SDS-PAGE and blotting 
with HRP-ExtrAvidin
®. EWI-2* is a 50-kD EWI-2 cleavage fragment. 
Densitometry revealed that CD9 and CD81 depletion removed only 
 10% of total  3 integrin, but  85% of the  3-associated EWI-2. 
Densitometry of an independent experiment confirmed that only 
 10% of  3 is CD81-associated in A431 cells (not depicted). 
(B) U937 cells lacking CD9 and CD81 were transduced with CD81 
and EWI-2 retroviral expression vectors and selected to obtain stable 
(CD81 , EWI-2 ) or (CD81 , EWI-2 ) cell lines. Then, both cell 
types were super-infected with an  3 integrin retroviral expression 
vector, to yield equivalent  3 expression levels, as confirmed by 
flow cytometry (not depicted). EWI-2 (M2 anti-FLAG mAb), CD81 
(M38 mAb), or  3 integrin (A3X8 mAb) were immunoprecipitated 
from 1% Brij 96 lysates of CD81
  or CD81
  cells. Immunoprecipitates 
were blotted for EWI-2 (biotinylated M2 anti-FLAG mAb),  3 integrin 
(D23 pAb), or CD81 (M38 mAb). Apparent mature and immature 
forms of EWI-2 and  3 integrin are indicated with filled and open 
arrows, respectively. 6   10
6 cell equivalents were analyzed in 
EWI-2 and CD81 immunoprecipitations, and 4.8   10
7 cell equivalents 
in the  3 immunoprecipitations. (C) Biotinylated CD81
  or CD81
  
cells were lysed in 1% Brij 96, and EWI-2 (FLAG),  3 integrin, or 
CD81 were immunoprecipitated as above. Cell surface–labeled 
proteins were revealed by HRP-ExtrAvidin
® blot. 1.7   10
6 cell 
equivalents were analyzed in each immunoprecipitation.EWI-2 regulates integrin functions | Stipp et al. 1173
EWI-2 mutant (EW2xCD2c) retains  3 1 association, 
but shows other biochemical deficiencies
Immunoprecipitation of FLAG-tagged EW2xCD2c and
EWI-2 yielded similar amounts of associated  3 integrin as
seen either by immunoblotting (Fig. 9 A, top; lanes 2 and 3)
or by cell surface biotin labeling (Fig. 9 B, top; lanes 2 and
3). However, the EW2xCD2c protein showed substantially
diminished association with CD81. CD81 was detected by
blotting in immunoprecipitates of EWI-2 (Fig. 9 A, middle;
lane 3), but not EW2xCD2c (Fig. 9 A, lane 2). Consis-
tent with CD81-dependent maturation results in Fig. 8 B,
the EW2xCD2c protein (with impaired CD81 association)
showed a lower ratio of mature/immature forms (Fig. 9 A,
bottom; compare lane 2 with lane 3). Consistent with re-
tarded maturation, EW2xCD2c and EWI-2 showed similar
levels of total FLAG-tagged protein (Fig. 9 A, bottom), but
the amount of surface-labeled EW2xCD2c was somewhat
diminished compared with EWI-2 (Fig. 9 B, compare lane 2
with lane 3).
If tetraspanin CD81 association is greatly diminished,
then how does EW2xCD2c maintain  3 integrin asso-
ciation in the absence of this critical linker protein?
EW2xCD2c (compared with EWI-2) retained diminished
but readily detectable association with tetraspanin CD9,
whereas CD81 was barely detectable even in the longer ex-
posure (Fig. 9 B, lanes 2 and 3). In another experiment, im-
munoprecipitation of CD81 yielded no EW2xCD2c (Fig. 9
C, top; lane 3) and EW2xCD2c yielded no CD81 (Fig. 9 C,
bottom; lane 1), whereas immunoprecipitation of CD9
yielded clearly detectable EW2xCD2c protein, exclusively in
its mature form (Fig. 9 C, compare lanes 1 and 2 with lanes
1* and 2*). Notably, the level of mature EW2xCD2c in the
CD9 immunoprecipitation (Fig. 9 C, lane 2) exceeded the
level of mature EW2xCD2c present in the  3 integrin im-
munoprecipitation (Fig. 9 C, lane 4). Hence, even in the ab-
sence of CD81 association, there is sufficient EW2xCD2c-
associated CD9 to allow linkage to  3 integrin.
Evidence for extended EWI-2–CD81– 3 1 complexes
Several experiments suggest that additional CD81 and
EWI-2 molecules may be appended to EWI-2–CD81– 3 1
and EWI-2–CD9– 3 1 “core” complexes, but not to
EW2xCD2c CD9  3 1 core complexes. For example,
immunoprecipitations of EWI-2 and EW2xCD2c yielded
similar levels of associated  3 (Fig. 9, A and B), but immu-
noprecipitations of CD9, CD81, or  3 each yielded more
EWI-2 than EW2xCD2c (Fig. 9 C, top; compare lanes 6–8
with lanes 2–4). In addition, from EWI-2–transfected A431
cells, immunoprecipitations of EWI protein, CD9, or  3
each yielded more CD81 (Fig. 9 C, bottom; compare lanes
5, 6, and 8 with lanes 1, 2, and 4). In Fig. 9 D, immunopre-
cipitation of  3 again yielded much more CD81 from EWI-
2–expressing A431 cells (Fig. 9 D, lane 3), than from
EW2xCD2–expressing cells (Fig. 9 D, lane 2). Together,
these results suggest that although EW2xCD2c is adequate
for assembly into core (EWI–CD9– 3 1) complexes, its
Figure 9. Biochemical analysis of the 
EW2xCD2c chimera. (A) Wild-type and 
mutant EWI proteins were immunopre-
cipitated using anti-FLAG antibody, and 
then samples were analyzed by blotting 
using anti- 3, anti-CD81 (M38), and 
anti-FLAG pAbs. CD81 coprecipitating 
with EWI-2 is indicated with a small 
black arrow (middle). On the bottom, 
dark arrows indicate mature EWI proteins, 
and white arrows indicate immature 
forms. (B) From Brij 96 lysates of 10
6 cell 
surface–biotinylated, transduced A431 
cells, EWI proteins were immunoprecip-
itated using anti-FLAG antibody, and 
then analyzed by HRP-ExtrAvidin
® 
blotting. The locations of  3 integrin, 
intact EW2xCD2c, intact EWI-2, CD9, 
and CD81 are indicated. Two exposures 
of the same blot are presented to allow 
comparison of the relative amounts of 
 3, CD9, and CD81 that coprecipitate 
with each protein. Note that intact 
EW2xCD2 ( 78 kD) and intact EWI-2 
( 70 kD) are each accompanied by two 
smaller cleavage products. (C) 3.6   10
6 
A431 cells expressing EW2xCD2c or 
EWI-2were lysed in Brij 96, and the 
indicated proteins were immunoprecipi-
tated. Samples were then immunoblotted 
for FLAG (M2 anti-FLAG mAb) or CD81 
as above. In all cases, small differences in total protein in the lysates were measured by amido black assay and corrected before immunopre-
cipitation. Lanes 1* and 2* represent shorter exposures of lanes 5 and 6, respectively. (D)  3 integrin was immunoprecipitated from Brij 96 
lysates of 3.3   10
5 transduced A431 cells. Levels of CD81 and  3 within the immunoprecipitates were revealed by immunoblotting with 
M38 anti-CD81 mAb (top) or with anti- 3 pAb (bottom).1174 The Journal of Cell Biology | Volume 163, Number 5, 2003
loss of CD81 association coupled with diminished surface
expression limits the recruitment of additional CD81 and
EWI proteins (Fig. 10; see Discussion).
Discussion
EWI-2 regulates epidermoid cell reaggregation and 
motility on laminin-5
Here, we establish that the IgSF protein EWI-2 associates
with  3 1 integrin (a major laminin-5 receptor) and acts as
a negative regulator of epithelial cell reaggregation and mo-
tility on laminin-5. Expression of EWI-2 at approximately
fourfold elevated levels in A431 cells had essentially no effect
on expression levels of other molecules ( 3 1, other inte-
grins, and associated tetraspanins CD9 and CD81) or on
cell viability on laminin-5. Likewise, EWI-2 expression did
not alter  3 1 integrin–dependent cell adhesion, the extent
of cell spreading on laminin-5,  3 1 subcellular localiza-
tion, or adhesion-stimulated FAK phosphorylation (unpub-
lished data). Hence, we infer that EWI-2 did not alter  3 1
integrin affinity for ligand, or initial  3 1-dependent cell
adhesion. Instead, EWI-2 exerted a highly specific effect on
a select few functions (cell reaggregation and motility) that
occur after cell attachment and spreading.
EWI-2 neither associated with  2 1 integrin nor affected
reaggregation of A431 EWI-2 cells on collagen I, an  2 1
ligand. Although EWI-2 did reduce the mean A431 cell mi-
gration rate on collagen I (by  30–50%; unpublished data),
this effect was not as great as that seen on laminin-5 (60–
70%). This result is consistent with  3 1 functioning to
some extent as a secondary receptor on a wide range of
ligands to which it does not mediate initial attachment
(DiPersio et al., 1995). The results also suggest a nonlinear
correlation between cell migration and cell reaggregation,
such that reaggregation is strongly affected by large changes
in migration, but is disproportionately less affected by smaller
changes in cell migration. Integrin  6 4 also did not associ-
ate with EWI-2 and, compared with  3 1, contributed
much less to cell spreading on laminin-5. This is in accord
with earlier analyses, in which  6 4 integrin contributed to
cell attachment on laminin-5, but  3 1 was required for cell
spreading (Xia et al., 1996; DiPersio et al., 1997).
Our results yield notable clues regarding the mechanism
for EWI-2 effects on  3 integrin–dependent function. First,
EWI-2 caused tetraspanin CD81 protein to localize into
filopodia at the cell periphery, an ideal position in which to
affect cell migration. Second, EWI-2 promoted an increased
biochemical association of CD81 with  3 1 integrin. A
mutant form of EWI-2 (EW2xCD2c) that failed to associate
with CD81, and also did not inhibit cell migration on lami-
nin-5, in parallel failed to redirect CD81 to filopodia and
failed to enhance CD81– 3 1 association. We propose that
EWI-2–dependent redirection of CD81 into proximity with
filopodial  3 1 should also lead to enhanced recruitment of
CD81-associated cytoplasmic signaling enzymes, such as
classical PKC isoforms and PI 4-kinase (Berditchevski et al.,
1997; Zhang et al., 2001). These enzymes, together with
other CD81-associated molecules, would then be in position
to influence  3 1-mediated cell migration.
Transmembrane proteins CD98, CD36, and CD47 all as-
sociate with various  1 and/or  3 integrins and modulate
adhesive and/or motility functions (Thorne et al., 2000;
Brown and Frazier, 2001; Fenczik et al., 2001). However,
those molecules associate with integrins in the context of
detergent-insoluble light membranes (Green et al., 1999;
Thorne et al., 2000; Kolesnikova et al., 2001), whereas
EWI-2–tetraspanin and tetraspanin– 3 1 associations oc-
cur within detergent-soluble fractions (Claas et al., 2001;
Stipp et al., 2001a). Another member of the EWI subfam-
ily, EWI-F/CD9-P1, can also associate with  3 1 integrin
(Charrin et al., 2003b), but the functional consequences
have not yet been determined. In another analysis, EWI-2
overexpression impaired prostate cancer cell migration on
laminin-1 and fibronectin (Zhang et al., 2003), but EWI-2
association with integrins was not studied, and the mecha-
nism of EWI-2 function was not addressed.
EWI-2 association with  3 1 is mediated by 
tetraspanins CD9 and CD81
Several observations point to EWI-2 association with
 3 1 being mediated by tetraspanins CD9 and CD81.
First, in lysates depleted for CD9 and CD81, the major-
ity of EWI-2 associated with  3 1 was removed, even
though the majority of  3 1 itself remained undepleted.
Thus, EWI-2 is linked, via tetraspanins, to a small but
critical subset of  3 1. Second, more integrin was recov-
ered in a CD9 immunoprecipitation than in EWI-2 im-
munoprecipitation; and more EWI-2 was recovered by
Figure 10. Hypothetical model of EWI-2- 3 1 and EW2xCD2c-
 3 1 complexes. (A) CD9 links EW2xCD2c to integrin  3 1-CD151 
complex. Only the “core” complex is shown because EW2xCD2c 
is unable to associate with CD81. (B and C) Either CD9 or CD81 
is capable of linking EWI-2 to  3 1 integrin in the core complex. 
However, overexpression of wild-type EWI-2 (but not EW2xCD2c) 
results in extension of the core complex to include additional EWI-2 
and CD81. Hence, we can explain why immunoprecipitation of 
either EW2xCD2c or EWI-2 yields similar levels of associated  3 1, 
whereas immunoprecipitation of  3 1 yields abundant CD81 
and EWI-2 (in EWI-2–transfected cells), but not much CD81 and 
EW2xCD2c (in EW2xCD2c-transfected cells). The model also 
explains why more CD81 can associate with  3 1 when EWI-2 
is present. Compared with EW2xCD2c, EWI-2 expression also results 
in enhanced CD9–EWI-2 and CD9–CD81 complex formation 
(Fig. 9 C). However, these complexes are not indicated in the model 
because we do not know the extent to which they show association 
with  3 1.EWI-2 regulates integrin functions | Stipp et al. 1175
CD9 (or CD81) immunoprecipitation than by anti- 3 1
(or CD151) immunoprecipitation. Again, this supports
the idea that CD9 and CD81 are each more proximal to
both the integrin and the EWI-2 than the integrin is to
EWI-2. Third, CD9 and CD81 can associate with EWI-2
under conditions in which no integrin is present (Stipp et
al., 2001a), and CD81 can associate with integrins under
conditions in which no EWI-2 appears to be present
(Zhang et al., 2001). Fourth, in U937 cells lacking CD9
and CD81, EWI-2 failed to associate with  3 1 unless
CD81 was coexpressed. Finally, the EW2xCD2 mutant,
lacking CD81 association capability, instead used CD9
for linkage to  3 1 (Fig. 10). These results strongly sup-
port a model in which either CD9 or CD81 can link EWI
protein to  3 1. Differences between CD9 and CD81,
with respect to EW2xCD2 association, suggest that the
EWI-2 cytoplasmic tail could be more important during
CD81 association.
Our works reveal a novel function for CD81 in EWI-2
trafficking. First, in the absence of CD81 (or CD9), lit-
tle EWI-2 underwent full biosynthetic maturation and
appeared on the surface of U937 cells. Second, the
EW2xCD2c mutant, deficient in CD81 association, also
showed impaired maturation and cell surface expression. In
the latter case, retention of CD9 association likely accounted
for a significant fraction of EW2xCD2c maturing, reaching
the cell surface, and engaging  3 1 to the same extent that
EWI-2 engages  3 1. The finding that only  10% of the
 3 1 is involved in a complex with tetraspanins and EWI-2
helps to explain why EW2xCD2c and EWI-2 both engage a
similar fraction of  3 1, despite the lower cell surface ex-
pression of EW2xCD2c. The 10%  3 1 estimation is con-
sistent with previous estimates of  3 1–tetraspanin stoichi-
ometry (Berditchevski et al., 1996). However, for the critical
subset of  3 1 molecules engaged with ligand in filopodia
at the cell periphery, EWI-2–tetraspanin– 3 1 association
may be much greater than 10%.
Expanded EWI-2–CD81– 3 1 complexes include 
additional CD81 and EWI-2 molecules
Both EWI-2 and the EW2xCD2c mutant were similarly
linked via tetraspanins (CD81 and/or CD9) to the  3 1 in-
tegrin. However, EWI-2 suppressed cell migration and en-
hanced the recruitment of CD81 to critical filopodial sites,
whereas the EW2xCD2c mutant had neither of these activi-
ties. To explain these key functional differences, we look be-
yond the core EWI–tetraspanin– 3 1 complexes and con-
sider the role of expanded complex formation. As illustrated
in Fig. 10, both mutant and wild-type EWI-2 are linked to a
similar extent to  3 1, with EW2xCD2c using CD9, and
EWI-2 using CD9 or CD81. However, with CD81 associa-
tion leading to more EWI-2 cell surface expression, there is
capability to assemble additional CD81 and EWI-2 mole-
cules into an expanded complex. Hence, CD81 not only
links EWI-2 to  3 1, but EWI-2 also helps to recruit more
CD81 to  3 1. The tendency of CD81 and CD9 to exist as
homodimers (Kovalenko et al., 2003) should facilitate ex-
tension of the complex. Lacking an ability to associate with
CD81, the EW2xCD2c mutant cannot support expanded
complex formation.
Tetraspanin-enriched microdomains contain cholesterol,
gangliosides, tetraspanins, and other proteins. These micro-
domains, held together at least partly due to tetraspanin
palmitoylation, are physically and functionally distinct from
lipid rafts (Berditchevski, 2001; Boucheix and Rubinstein,
2001; Hemler, 2003). Our EWI-2–tetraspanin– 3 1 results
extend the “tetraspanin microdomain” idea by demonstrat-
ing that multiple nontetraspanin proteins (an integrin and
EWI-2) can be physically and functionally linked through
specific tetraspanin proteins. The association of EWI-F/
CD9-P1 with  3 1 integrin provides another potential ex-
ample of tetraspanins linking two nontetraspanin proteins,
although the tetraspanins involved were not formally defined
(Charrin et al., 2003b). Other examples of multiprotein
complexes potentially linked by tetraspanins, such as  4 1
and  6 1 integrin with HLA-DR, (Rubinstein et al., 1996)
and HB-EGF with  1 integrin (Nakamura et al., 1995), re-
lied on mild CHAPS detergent conditions in which tetraspa-
nin complexes can have sizes in excess of 20 million D (Sku-
bitz et al., 2000). Also, the linker function of tetraspanins
was not directly tested in these experiments, and the func-
tional relevance of the complexes was not established. Com-
plexes of CD19 with CD21 (Horvath et al., 1998), and
CD36 with  3 1 or  6 1 integrin (Thorne et al., 2000) are
stable in Brij96 and may be functionally relevant, but the
role of tetraspanins as linkers in these complexes remains un-
tested. In another work, we found that EWI-2 can interact
with another CD81-associated integrin ( 4 1) in the
MOLT-4 T cell line to cause formation of expanded EWI-
2–CD81– 4 1 complexes, leading to alterations in  4 1-
dependent cell morphology (unpublished data).
Possible relevance in vivo
In zones of activated basement membrane underlying in-
jury sites, cell migration on laminin-5 is mediated primar-
ily by  3 1 integrin (Nguyen et al., 2000). Laminin-5 can
also trigger  3 1-dependent scattering of squamous carci-
noma cells (Kawano et al., 2001), suggesting a potential
role for  3 1 in metastasis. On the other hand,  3 1
overexpression in the suprabasal layer of the epidermis in-
hibited malignant conversion of papillomas (Owens and
Watt, 2001), suggesting a potential role for  3 1 in sup-
pressing tumor progression in some circumstances. In all of
these cases, EWI-2 could play a key regulatory role, given
its relatively widespread distribution (Clark et al., 2001;
Stipp et al., 2001a). In addition, EWI-2 could participate
in several key developmental processes. The defects of  3-
null mice in kidney, lung, and skin morphogenesis point to
a critical role for  3 1 in the assembly or organization of
laminin-5 in the basement membranes of these tissues
(Kreidberg et al., 1996; DiPersio et al., 1997). EWI-2 may
participate in these functions by regulating the outcome of
 3 1 engagement of laminin-5.
In conclusion, we have established a novel structural and
functional link, via CD9 and CD81, between EWI-2 and
the  3 1 integrin. These results contribute to the emerg-
ing importance of tetraspanin-containing protein microdo-
mains, and also establish a novel means of regulating integrin
function through lateral interactions among transmembrane
proteins.1176 The Journal of Cell Biology | Volume 163, Number 5, 2003
Materials and methods
Antibodies
mAbs to integrin  2 (A2-IIE10),  3 (A3-X8 and A3-IIF5),  6 (A6-ELE), and
to tetraspanins CD81 (M38 and JS64) and CD151 (5C11) were referenced
previously (Kazarov et al., 2002; Yang et al., 2002). Other mAbs were anti-
integrin  6 (GoH3; BD Biosciences), anti-CD9 (ALB6; CHEMICON Inter-
national), and anti-CD151 (8C3; a gift from Dr. Kiyotoshi Sekiguchi, Osaka
University, Japan). Anti- 3 antibody A3-X8, anti-CD81 antibody M38, and
anti-CD151 antibody 5C11 were used in all cases, except where specified.
The M2 anti-FLAG epitope mAb, either biotinylated or conjugated to aga-
rose, and a rabbit anti-FLAG pAb were purchased from Sigma-Aldrich.
HRP-conjugated goat-anti–mouse pAb was purchased from Transduction
Laboratories, and HRP-ExtrAvidin
® was purchased from Sigma-Aldrich.
M38 anti-CD81, A2-IIE10 anti- 2, and A3-X8 anti- 3 antibodies were
conjugated to agarose Affigel-10 (Pierce Chemical Co.) according to man-
ufacturer’s instructions.
Cell culture and retroviral transduction
A431 epithelial carcinoma cells and retroviral packaging cell lines  NX
and PT67 were cultured in high glucose DME, and U937 pro-monocytic
leukemia cells in RPMI 1640. All cultures were supplemented with 10%
FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100  g/ml streptomycin
(all purchased from GIBCO BRL). Expression constructs were (1) a COOH-
terminally FLAG-tagged EWI-2 in the pLXIZ retroviral vector (Stipp et al.,
2001a); (2) also in pLXIZ, an EWI-2/CD2 chimera (EW2xCD2c) with the
EWI-2 cytoplasmic tail (from Cys
604) replaced by recombinant PCR with
the tail of CD2 followed by the FLAG epitope; (3) human CD81 in the
pLXIN retroviral vector; (4) human  3 integrin in pLXIZ; and (5) the empty
pLXIZ vector. Expression vectors were transfected by calcium phosphate
into  NX packaging cells. 48 h after transfection,  NX cell supernatants
were passed through a 0.45- m filter, supplemented with 4  g/ml Poly-
brene
® (Sigma-Aldrich), and used to infect PT67 packaging cells that had
been pretreated with 200 ng/ml tunicamycin (Sigma-Aldrich) for 18 h. Sta-
ble PT67 packaging cells were obtained by selection for 2 wk in 500  g/ml
Zeocin™ (Invitrogen) or G418. The supernatant from these PT67 cells was
harvested, filtered, and supplemented with Polybrene
® as above, and then
used to infect A431 cells or U937 cells. Stable infectants were selected
and grown as uncloned populations.
Cell spreading assay
Serum-free medium (SFM) contained DME with 5 mg/ml cell culture grade
BSA (#194771; ICN Biomedicals) and 20 mM Hepes, pH 7.2. A431 EWI-2
cells and A431 IZ cells were rinsed, detached by trypsin/EDTA treatment,
and collected in SFM plus 0.1 mg/ml soybean trypsin inhibitor and 0.1 mg/
ml DNase I (both purchased from Worthington Biochemical Corp.). After
centrifugation, the supernatant was removed and cells were resuspended
in SFM alone or SFM with (1) 5  g/ml GoH3 anti- 6, (2) 10  g/ml A3-IIF5
anti- 3, or (3) both antibodies. Cells were then plated on acid-washed
glass coverslips that had been coated with 1  g/ml rat laminin-5 (provided
by Desmos, Inc.) and blocked with SFM. Cells attached and spread for 20
min before being fixed with 3.7% formaldehyde in PBS with 5% sucrose
and 2 mM MgCl2 for 15 min at RT. Coverslips were rinsed and mounted on
slides in FluoroSave reagent (Calbiochem). Cell images were acquired with
a monochrome CCD camera (Spot RT; Diagnostic Instruments) on a micro-
scope (Axiovert 135; Carl Zeiss MicroImaging, Inc.), and were controlled
by IP Lab software (Scanalytics) running on a G4 Macintosh computer. Ar-
eas of cells (20–45 cells per coverslip) were calculated using the Scion Im-
age v1.62 program (Scion Corp.).
Reaggregation assay
Acid-washed glass coverslips (12-mm circles) were coated overnight at
4 C with 0.5  g/ml rat laminin-5 in PBS with 0.005% Tween 20, or with
40  g/ml collagen I in PBS. Coverslips were then blocked for 1 h at RT
with SFM. A431 EWI-2 and A431 IZ cells that had been starved overnight
in SFM were harvested as for the spreading assay above, and 1.5   10
5
cells per well were plated to laminin-5– or collagen I–coated coverslips in
a 24-well dish. After 5–6 h, cells were fixed, stained with DAPI HCl
(Sigma-Aldrich) to label nuclei, mounted, and imaged as above. Clustered
and unclustered cells were counted in five fields per coverslip (typically
 500 cells per coverslip). Two coverslips per condition were examined in
each experiment, and always yielded statistically similar results. DAPI
staining enabled unambiguous scoring of cell numbers in large, tightly
packed cell clusters. Viability of A431 EWI-2 cells and A431 IZ cells under
these assay conditions was tested using thiazolyl blue tetrazolium bromide
(MTT) in Cell Proliferation Kit I (Roche).
Immunofluorescent localization
A431 cells were plated on laminin-5 in SFM. After 3 h, cells were fixed for
15 min with prewarmed 4% PFA, 2 mM MgCl2, and 4% sucrose in PBS.
Fixed cells were rinsed three times with 50 mM Tris-HCl, pH 7.4, and 150
mM NaCl, and were blocked for 30 min in 20% goat serum in PBS. Pri-
mary antibodies were added at 5  g/ml in blocking buffer and allowed to
bind overnight at 4 C. After rinsing in PBS, FITC-goat anti–mouse second
antibody was added in blocking buffer for 1 h at RT. Rinsed coverslips
were mounted in FluoroSave (Calbiochem). Fluorescent images were ac-
quired on an upright microscope (Axioskop; Carl Zeiss MicroImaging, Inc.)
using a Spot RT camera driven by IP Lab software, as described above.
Immunoprecipitation, immunoblotting, and immunodepletion
A431 cells were lysed by scraping into 20 mM Hepes, pH 7.5, 150 mM
NaCl, and 5 mM MgCl2 (HBSM) supplemented with 1% Brij 96 (Fluka), 2
mM PMSF (Sigma-Aldrich), 20  g/ml aprotinin, and 10  g/ml leupeptin
(Boehringer). In some experiments, cells were biotinylated with 0.2 mg/ml
sulfo-NHS-LC biotin (Pierce Chemical Co.) in HBSM for 1 h at RT, then
rinsed three times with HBSM before lysis. After a 1-h extraction at 4 C
with rocking, insoluble material was removed by centrifugation, and ly-
sates were precleared for 1 h at 4 C with protein G–Sepharose (BD Bio-
sciences). M2 anti-FLAG agarose or specific antibodies plus protein
G–Sepharose were added, and immune complexes were collected over-
night at 4 C. After rinsing four times with lysis buffer, immune complexes
were eluted by boiling in sample buffer, resolved by SDS-PAGE, and trans-
ferred to nitrocellulose. Blots were blocked with 5% nonfat milk in PBS
with 0.1% Tween 20.
FLAG epitope immunoblots were rinsed with TBS and blotted for 30
min with biotinylated M2 anti-FLAG mAb (10  g/ml in TBS). After 10
rinses, blots were developed with a 30-min exposure to HRP-ExtrAvidin
®
in TBS, followed by 10 more rinses, and chemiluminescence detection
(Renaissance
® reagent; NEN Life Science Products). Myc epitope and
CD151 immunoblots were developed for 1 h with anti-myc 9E10 ascites or
the 8C3 anti-CD151 mAb diluted in blocking buffer, followed by 1 h with
an HRP-goat anti–mouse pAb and chemiluminescence.
For immunodepletion, cell surface–biotinylated cells were lysed in 1%
Brij 96 as described above. The lysate was divided into four parts and pre-
cleared three times for 1 h with (1) protein G–Sepharose alone, (2) protein
G–Sepharose plus a combination of M38 and ALB6, anti-CD81, and CD9
antibodies, or (3) protein G–Sepharose plus A2-IIE10 anti- 2 integrin. The
depleted samples were further divided into three parts each, immunopre-
cipitated with agarose-conjugated anti-CD81, anti- 3, or anti- 2 antibod-
ies, and then analyzed by SDS-PAGE and chemiluminescence as above.
Semi-quantitative densitometry was performed using GeneTools software
(Syngene) on digitized images captured from trans-illuminated films with a
CCD camera driven by GeneSnap software (Syngene).
Online supplemental material
Video 1 shows that EWI-2 overexpression impairs carcinoma cell motility
on laminin-5. A431 IZ cells (left) and A431 EWI-2 cells (right) were plated
on laminin-5 in serum-free medium. Migration was monitored for 2 h at 1
frame/min, and the video play rate is 6 frames/s. Online supplemental ma-
terial available at http://www.jcb.org/cgi/content/full/jcb.200309113/DC1.
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